Charles River Laboratories (CRL) Tops Q2 EPS by 7c, Updates Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. AMD
3. PLTR
4. CRWD
5. DOX
6. VRTX
7. CHKP
8. ON
9. HNGE
10. INSP

Go back to Charles River Laboratories (CRL) Tops Q2 EPS by 7c, Updates Guidance

Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing Operations

August 9, 2017 7:00 AM EDT

Second-Quarter Revenue of $469.1 Million

Second-Quarter GAAP EPS of $1.12 and Non-GAAP EPS of $1.29

Updates 2017 Guidance

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2017. Revenue from continuing operations was $469.1 million, an increase of 8.1% from $434.1 million in the second quarter of 2016. Revenue growth was driven primarily by the Discovery and Safety Assessment and Manufacturing Support segments.

The acquisitions of Agilux Laboratories, WIL Research, and Blue Stream Laboratories contributed 3.9% to consolidated second-quarter revenue... More